Compare HALO & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | SWK |
|---|---|---|
| Founded | 1998 | 1843 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 13.0B |
| IPO Year | 2001 | 2009 |
| Metric | HALO | SWK |
|---|---|---|
| Price | $108.28 | $98.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $78.64 | ★ $84.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.9M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | N/A | ★ 35.90 |
| EPS | ★ 3.11 | 2.71 |
| Revenue | $151,862,000.00 | ★ $15,130,400,000.00 |
| Revenue This Year | $28.24 | $1.56 |
| Revenue Next Year | $12.56 | $2.10 |
| P/E Ratio | ★ $34.78 | $36.91 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.23 | $61.90 |
| 52 Week High | $108.49 | $104.68 |
| Indicator | HALO | SWK |
|---|---|---|
| Relative Strength Index (RSI) | 77.65 | 53.73 |
| Support Level | $67.12 | $72.96 |
| Resistance Level | N/A | $104.68 |
| Average True Range (ATR) | 3.53 | 2.49 |
| MACD | 0.75 | -0.76 |
| Stochastic Oscillator | 97.08 | 23.59 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Stanley Black & Decker Inc offers hand tools, power tools, outdoor products, engineered fastening solutions, and related accessories. The company operates in two reportable business segments: Tools & Outdoor and Engineered Fastening. The majority of its revenue is generated from the Tools & Outdoor segment, which is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) product lines. This segment's product offerings include drills, impact wrenches and drivers, grinders, saws, hammers, demolition tools, clamps, vises, knives, edge trimmers, lawn mowers, etc., which are offered through brands like Hustler, Dewalt, Craftsman, Stanley, and others. Geographically, the firm derives maximum revenue from the United States.